Emma L. Reuschel, Ph.D.
Affiliations: | 2014 | Cell and Molecular Biology | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Cell Biology, ImmunologyGoogle:
"Emma Reuschel"Parents
Sign in to add mentor| Terri H. Finkel | grad student | 2014 | Penn | |
| (REDD1 as a stress response gene in mature T cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Walters JN, Schouest B, Patel A, et al. (2022) Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates. Vaccine. 40: 2960-2969 |
| Xu Z, Walker S, Wise MC, et al. (2022) Induction of tier-2 neutralizing antibodies in mice with a DNA-encoded HIV envelope native like trimer. Nature Communications. 13: 695 |
| Konrath KM, Liaw K, Wu Y, et al. (2022) Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protection. Cell Reports. 110318 |
| Kraynyak KA, Blackwood E, Agnes J, et al. (2022) SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial. The Journal of Infectious Diseases |
| Andrade VM, Christensen-Quick A, Agnes J, et al. (2021) INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants. Npj Vaccines. 6: 121 |
| Patel A, Walters JN, Reuschel EL, et al. (2021) Intradermal-delivered DNA vaccine induces durable immunity mediating a reduction in viral load in a rhesus macaque SARS-CoV-2 challenge model. Cell Reports. Medicine. 100420 |
| Tebas P, Roberts CC, Muthumani K, et al. (2021) Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine. The New England Journal of Medicine. 385: e35 |
| Patel A, Reuschel EL, Xu Z, et al. (2021) Intradermal delivery of a synthetic DNA vaccine protects macaques from Middle East respiratory syndrome coronavirus. Jci Insight |
| Tebas P, Yang S, Boyer JD, et al. (2020) Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial. Eclinicalmedicine. 100689 |
| Choi H, Kudchodkar SB, Ho M, et al. (2020) A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus. Plos Neglected Tropical Diseases. 14: e0008788 |